Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A journey toward understanding the vasopressin type 2 receptor function; impact of small molecules and structural biology. | Mol Cell Endocrinol | 2026 | 42229615 | PubTator, text mining | PubMed |
| Efficacy and safety of tolvaptan in rapidly progressing autosomal dominant polycystic kidney disease: a single-center, prospective, single-arm study. | Transl Androl Urol | 2026 | 42164351 | PubTator, text mining | PubMed |
| Local GPCR density tips the balance of μ-opioid receptor trafficking. | bioRxiv | 2026 | 42124644 | PubTator, text mining | PubMed |
| Amyloid-Inspired Synergistic Short Peptide Scaffold against Mitochondrial Dyshomeostasis in Traumatic Brain Injury. | ACS Biomater Sci Eng | 2026 | 42095283 | PubTator, text mining | PubMed |
| Discrimination of aliphatic and aromatic hydrocarbons via modulated folding and fluorescence of an NDI-tetramer. | Chem Commun (Camb) | 2026 | 42065443 | PubTator, text mining | PubMed |
| Cooperative Control of Arrestin Activation By Membrane Lipids And Phosphorylation Barcodes. | bioRxiv | 2026 | 42039491 | PubTator, text mining | PubMed |
| Novel Roles of GPCRs in the Renal Collecting Duct. | Physiology (Bethesda) | 2026 | 41996347 | PubTator, text mining | PubMed |
| Identification of a novel large deletion mutation in the AVPR2 gene responsible for hereditary nephrogenic diabetes insipidus in an infant: a case report. | Transl Pediatr | 2026 | 41982965 | PubTator, text mining | PubMed |
| SAR-Guided Scaffold Innovation of Selective V2R Antagonists: Therapeutic Frontiers in ADPKD. | ACS Med Chem Lett | 2026 | 41982737 | PubTator, text mining | PubMed |
| Social Media Promotion of Raw Date Palm Sap and Emerging Nipah Virus Transmission Risk in Bangladesh: Descriptive Analysis of Multisource Data. | JMIR Form Res | 2026 | 41926155 | PubTator, text mining | PubMed |
| The effects of elevated phosphate on the kidney - damaging the gatekeeper. | Pflugers Arch | 2026 | 41906060 | PubTator, text mining | PubMed |
| Machine learning-based predictive models and subtypes patterns in peripheral blood of schizophrenia based on a machine learning computational framework. | Schizophrenia (Heidelb) | 2026 | 41876515 | PubTator, text mining | PubMed |
| Author Correction: Structural insights into antagonist recognition by the vasopressin V2 receptor. | Nat Commun | 2026 | 41872156 | PubTator, text mining | PubMed |
| Machine Learning Prediction of Progression to Dialysis in Patients With Polycystic Kidney Disease: Population-Based Retrospective Cohort Study. | JMIR Med Inform | 2026 | 41838891 | PubTator, text mining | PubMed |
| Genetic background of infantile hypophosphatemia: a narrative review. | Transl Pediatr | 2026 | 41810186 | PubTator, text mining | PubMed |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Administration JMKX003142 in Chinese Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Single, and Multiple Ascending Dose Phase I Clinical Trial. | Drug Des Devel Ther | 2026 | 41810128 | PubTator, text mining | PubMed |
| Beyond expensive innovations: affordable and effective strategies for managing tubulopathies in adults. | Clin Kidney J | 2026 | 41800319 | PubTator, text mining | PubMed |
| Specific in vivo detection of V2R-positive metastatic ccRCC using a toxin-based PET radioligand. | Theranostics | 2026 | 41799197 | PubTator, text mining | PubMed |
| Heterogeneous regulation of fibroblast growth factor 23 in acute kidney injury, chronic kidney disease, and polycystic kidney disease: mechanisms, diagnostic utility, and clinical implications. | Front Mol Biosci | 2026 | 41783140 | PubTator, text mining | PubMed |
| Detection of plasma EV-associated TRAIL by nanoscale flow cytometry for liver metastasis prediction in PDAC. | Adv Biotechnol (Singap) | 2026 | 41779305 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=2